|
|
WHAT'S NEW
IBDoc® Talk- Tips & Tricks Teleconference
COMING SOON!
BUHLMANN Diagnostics Corp Announces New Partnership with Meridian Bioscience, Inc.
BUHLMANN Diagnostic Corp (BDC), Amherst, NH is proud to announce they have entered into a distribution agreement within the USA with Meridian Bioscience, Inc., Cincinnati, Ohio to market the FDA-cleared BÜHLMANN fCAL® ELISA for the quantitative measurement of fecal calprotectin in human stool.
Check out this video! In this recording, Daniel Turnock PhD, Consultant Clinical Biochemist and Susanna Rose, Healthcare Science Associate Practitioner from York Teaching Hospital NHS Foundation Trust discuss their experienced use of the BÜHLMANN fCAL ELISA. They reveal how clinicians use the calprotectin results and the patient pathway as well as other important details relevant to this test.
BÜHLMANN fCAL® ELISA Now Available in CAP Survey
BÜHLMANN fCAL® ELISA is now available in CAP surveys for proficiency testing! Find it Fecal Calprotectin (program code: FCAL) under General Chemistry in the 2019 CAP survey catalog.
UPCOMING EVENTS
Visit booth #842 to get an update on our Calprotectin and Therapeutic Drug Monitoring product portfolio.
RESOURCES AND RESEARCH
CITATIONS
Canadian Customers:
Below are three excellent new studies and a link to an in-depth summary using IBDoc® were published in recent months:
IBDoc®:
Walsh et al.: This is the first study that correlates fCAL values generated by patients using IBDoc® to endoscopic and histologic clinical assessments. The correlation coefficient between IBDoc® and histology (Nancy) was found to be 0.88 and at a cut-off 187 µg/g, sensitivity and negative predictive value was 100%.
Moore et al.: This study performed in three Canadian centers showed a very good correlation between the IBDoc® results generated by patients and the laboratory based BÜHLMANN fCAL® ELISA as well as high usability scores for the home test.
Wei et al.: This study in a Taiwanese IBD population proved very good correlation between the IBDoc® results generated by patients and the laboratory Quantum Blue® fCAL as well as a high usability score for the home test. A large majority of patients preferred the home-test over the laboratory method or endoscopy.
TECHNICAL NEWS
Basophils Are Still Alive
Quality Assay & Sample Stability for Viable Basophils
Basophil Activation Testing (often referred to as BAT) is a flow-cytometry-based functional assay that assesses the degree of cell activation after exposure to stimuli.
Do you know which BAT application makes sense for your lab? Are you thinking about implementing an allergy BAT? Or are you planning on using basophils as the new biomarker in your research project?
Learn more about BAT and how a quality assay and sample stability is key for viable basophils.
BÜHLMANN HIGHLIGHTS
Flow CAST® is intended for the determination of basophil activation in whole blood samples by flow cytometry. Thanks to its easy protocol and smart marker combination, the first results can be obtained in under an hour which provides perfect conditions for laboratories. Check out some interesting highlights for the Flow CAST® assay including interesting videos, eBooks, and more.
BUHLMANN DIAGNOSTICS CORP
BÜHLMANN is unique, independent, and reliable in every aspect of its business from the outstanding quality of its products, excellent after-sales services, and remarkable scientific innovations. The establishment of BDC is a statement of the importance of you, our customers and our commitment to understanding your needs. Our North American affiliate will help us to continue to foster closer relationships with our customers and enhance our customer support interactions as well as meet your requirements for future BÜHLMANN products. Quality is not just a statement, but part of our daily mission.
105 Route 101A, Suite 1,
Amherst, NH 03031 USA
Ph: (844) 300-9799
[email protected]
www.buhlmannlabs.com
|
